Inve India ▾

Anondita Medicare share price & results

Anondita Medicare Ltd· Fast Moving Consumer Goods

Results to
Mar 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

Noida-based manufacturer of male & female latex/non-latex condoms and sexual-wellness products under the COBRA brand.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue64.0 ₹ crore+77.8% YoYQuarterly, as filedQuarter to Mar 2026Revenue from operations as filed.
Operating margin35.0 %0.0 pts YoYOperating profit / revenueQuarter to Mar 2026For the quarter; a change is in percentage points.
Net profit15.0 ₹ crore+87.5% YoYQuarterly, as filedQuarter to Mar 2026Profit after tax as filed.
Return on equityUnavailable−0.8 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin-37.96 %−2.9 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable—Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Mar 2026

Guidance

What management said, and what became of it

10 targets tracked, none judged yet · 10 open · verdicts reflect calls analysed to Q4 FY26.

Anondita Medicare Ltd management guidance track record on Inve: 10 targets tracked across analysed earnings calls (0 achieved, 0 missed, 10 open).

TargetOriginal wordingSaidLatest callVerdict
Total RevenueTouch INR 1,000 crores revenue within the next 2 years
Call transcript, Q4 FY26 · 27 May 2026		Q4 FY26Q4 FY26:In response to an analyst question, management committed to reaching INR 1,000 crores in revenue within the next 2 years.
Call transcript, Q4 FY26 · 27 May 2026		New

Source: Inve Guidance Tracker for Anondita Medicare Ltd · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

10 of Anondita Medicare Ltd's 10 targets are still open. See which are on track and which have gone quiet. The 1 above are the free sample; 9 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,012.6 +3.36% · +₹32.95

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +116.9% 1Y

₹0.6k₹0.8k₹1.0k₹1.2kOct 25Dec 25Feb 26Mar 26May 26Jun 26Aug 26Sept 26Q4 FY26 — 27 May 2026

1Y: ₹466.85 on 24 Oct 2025 → ₹1,012.6. High ₹1,233.15 (24 Jun 2026), low ₹466.85 (24 Oct 2025).

Previous close
₹979.65
Market cap
₹1.9k Cr
52-week range
₹490.15 – ₹1,233.15
One year
+106.59%
Price to earnings (FY ending Mar 2026)
56.55×
Return on equity (FY ending Mar 2026)
39.76%

Overview

Symbol
NSE:ANONDITA
Exchange
NSE
Currency
INR

What Anondita Medicare Ltd does

Based on the company's own presentations, annual report and earnings calls.

Anondita Medicare manufactures male and female condoms and related sexual-wellness/healthcare products at its own facility in Noida, Uttar Pradesh, selling under its flagship COBRA brand while historically also contract-manufacturing for third-party pharma brands (including, in the past, Mankind Pharma's Manforce). It earns through a pan-India wholesale network of super stockists, distributors and retailers, supplemented by exports to select international markets. The company has recently added female latex condom production and has expanded the COBRA range into pregnancy test kits, lubricants and related tablets alongside its core condom and surgical-glove lines.

Annual installed condom production capacity
869 million pieces
Manufacturing lines
15 operational, plus 12 more under installation (WIP)
Manufacturing facility
Single integrated facility in Noida, Uttar Pradesh (~9,290 sq. mt. built-up area)
Distribution network
26 super stockists, 195 distributors, 4,569 retailers across India
Export markets
7 countries — Brazil, South Africa, Uzbekistan, Nepal, Kenya, Cuba, UAE
Production speed at full capacity
~12,100 condoms produced every 3 minutes
Headquarters Noida, Uttar Pradesh Company website

How the price took the results

close before → close after

Q4 FY26
−3.1%
27 May

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Anondita Medicare Ltd

Free account: one company. Everything above stays public.

Write why you follow Anondita Medicare Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Fast Moving Consumer Goods companies

All Fast Moving Consumer Goods companies → · Fast Moving Consumer Goods earnings growth →

Learn to analyse Anondita Medicare Ltd

Guides on how to read this kind of business and the numbers that matter.